Navigation Links
Dartmouth awarded lead role in NCI clinical trials network
Date:4/24/2014

(Lebanon, NH, 4/24/14) Dartmouth has been awarded one of 30 grants from the National Cancer Institute (NCI) to serve as a Lead Academic Participating Site in its new National Clinical Trials Network (NCTN). Award recipients are a select groups of investigators charged with distributing resources in a more effective way across fewer cooperative groups.

The NCTN grant system reflects recommendations from a 2010 Institute of Medicine Report. It streamlines operations to achieve four goals:

  • Faster design, launch, and completion of clinical trials

  • Optimal use of scientific innovations

  • Strategic prioritization of studies

  • Expanded participation of patients and physicians

Through a consolidation of operational resources, the NCTN untangles behind-the-scenes red tape by using:

  • A common IT data management systems

  • One Central Institutional Review Board

  • Integrated specimen banks and informatics systems

Everyonepatients, providers, and family memberswants to see faster access to new treatments for cancer, said Konstantin H. Dragnev, MD, principal investigator for the Dartmouth-Hitchcock Norris Cotton Cancer Center site. This new framework will cut the startup time for a clinical trial by 75 percent in some cases. It removes obstacles we used to face for reporting and oversight, so we can now offer therapeutic advances to patients sooner.

As a Lead Academic Participating Site, Norris Cotton Cancer Center will be charged with enhancing participation in NCI randomized phase three clinical trials, the gold standard in cancer research for establishing new treatments for a five year period. Participating sites provide scientific leadership in the development of clinical trials, while meeting performance benchmarks for quality clinical research. Dartmouth will oversee involvement and participation from affiliated patient enrollment settings in New Hampshire, Vermont, and other states.

As a group we can achieve more than we can individually, said Dragnev of the co-operative groups in the nationwide network. Urban and rural residents can participate in the same study, which expands our ability to include a more diverse population in an individual study. The Dartmouth-led affiliations also mean greater access to new therapies in relatively remote areas served in northern New England.

The new network represents an unmatched effort to integrate and streamline the process of cancer clinical trials research, said James Doroshow, MD, deputy director for clinical and translational research at NCI. The conduct of NCI-supported trials, which are publicly funded, involves a complex system of designing, reviewing, and initiating studies. The new NCTN replaces a structure that was more than 55 years old.

NCTN employs an inclusive process for generating studies and conducting clinical trials using broad representation from the oncology field, including academic researchers, as well as professional organizations, patients, and advocates.

The Network has combined smaller cooperative groups with specialized foci, such as, pediatric, breast/bowel, or gynecological cancers. These consolidated cooperative groups allow for closer communication and collaboration among researchers doing work in the same area. The newly announced Lead Academic Participating Sites will serve as common outlets for offering trials originating from any of these groups.

Norris Cotton Cancer Centers selection as a Lead Participating Site affirms our role as a national leader in cancer research, said Mark Israel, MD, director, Norris Cotton Cancer Center. We are among an elite group of investigators conducting nationally the highest caliber of scientific research.
'/>"/>

Contact: Donna Dubuc
Donna.M.Dubuc@Dartmouth.edu
603-653-3615
The Geisel School of Medicine at Dartmouth
Source:Eurekalert  

Related medicine news :

1. Dartmouth researchers develop new approach to chronic lymphocytic leukemia treatment
2. Dartmouth study provides first global evidence that foreign aid boosts public opinion
3. Dartmouth researcher finds novel genetic patterns that make us rethink biology and individuality
4. Clemson, Dartmouth use $1.5M grant to develop mobile health technology
5. Dartmouth researchers receive $5.9 million grant from NIH for lung research
6. Dartmouth researchers develop molecular switch that changes liquid crystal colors
7. Dartmouth researchers test safety of Nivolumab in kidney cancer
8. Leap in leukemia treatment reported by Dartmouth researchers
9. Dartmouth medical research closes in on new tuberculosis vaccine
10. Mayo Clinic, Dartmouth-Hitchcock announce collaboration
11. Dartmouth researchers investigate the cognitive effects of athlete head impacts
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Dartmouth awarded lead role in NCI clinical trials network
(Date:2/5/2016)... ... 05, 2016 , ... Freed-Hardeman University President Joe A. Wiley ... joint enrollment and degree completion agreement. The agreement, which begins with the ... FHU|Dickson. , The agreement allows students to be jointly admitted to both ...
(Date:2/5/2016)... ... February 05, 2016 , ... The American public tends to feel ... be safer than regular municipal or well water. The recent experience with lead contaminated ... could go a long way toward increasing public acceptance of recycled waste water as ...
(Date:2/5/2016)... York, New York (PRWEB) , ... February 05, 2016 , ... ... announced the election of Patrick McDermott as Chairman of the National Board of Directors. ... Pat as Chairman of the Board,” stated Leslie A. Chambers , APDA President ...
(Date:2/5/2016)... ... February 05, 2016 , ... In sleep, when the defenses of the ... hallmark feature of patients with eating disorders is significant self-criticism, and consequently these patients ... obsessions are regarded as maladaptive means for coping with this unease, but also leads ...
(Date:2/5/2016)... Boston, MA (PRWEB) , ... February 05, 2016 ... ... hosted its inaugural Columbia University Men’s Soccer Career Development event in New York ... KICVentures, and Rocco Commisso, Chairman and CEO of Mediacom, (both alumnus of the ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... , Feb. 5, 2016 ... addition of the "Global Obstetrics Partnering ... company profile to their offering. --> ... of the "Global Obstetrics Partnering 2010-2016: ... profile to their offering. --> ...
(Date:2/4/2016)...   Bernstein Liebhard LLP today announced that a ... District Court for the District of Arizona ... all persons or entities who purchased common shares of Insys ... from March 3, 2015 through January 25, 2016 (the "Class ... with violations of the Securities Exchange Act of 1934.  ...
(Date:2/4/2016)... LONDON , Feb. 4, 2016 ... and competitive market to drive long-term market growth ... very common set of chronic disorders that affect ... disparate in terms of their symptoms and key ... by dysregulation of immune pathways and an inappropriate ...
Breaking Medicine Technology: